Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Xue (Kate) Zhong, MD

702.483.6000

Xue (Kate) Zhong, MD

Appointed: 2010

Xue (Kate) Zhong, MD
Department: Cleveland Clinic Lou Ruvo Center for Brain Health
Associate Staff
Location: Lou Ruvo Center for Brain Health
Mail Code Las Vegas
888 W. Bonneville
Las Vegas, NV 89106
WorkAppointment:702.483.6000
WorkFax:702.483.6028
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Dr. Kate Zhong is the Senior Director of Clinical Research and Development for the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada and Cleveland, Ohio. She brings over 16 years of diversified clinical and pharmaceutical research experience to the Center. She is leading the clinical and research team conducting multiple trails to advance treatment in Alzheimer’s disease, Parkinson’s disease and other neurodegenerative disorders.

Dr. Zhong received her MD degree from West China University of Medical Sciences in Sichuan, China. She earned her Master Degree in Pharmacology and completed her residency in psychiatry at University of Toronto, Canada.

As the attending geriatric psychiatrist, Dr. Zhong gained extensive experiences in providing treatment and care for patients with neurocognitive disorders in Vancouver, Canada. While working as the Medical Director and Seroquel Brand Global Physician for one of the world's leading pharmaceutical company-AstraZeneca, Dr. Zhong led multiple global clinical trials in CNS therapeutic areas including Alzheimer’s disease, Schizophrenia, and mood disorders.

Dr. Zhong has been a scientific consultant for multiple pharmaceutical, biotech and patient recruitment companies. Dr. Zhong has provided multifaceted services to industry, academic centers and health care institutions both in US and in China. She assisted clients with the strategic planning and execution for due diligence, regulatory approval, market analysis, site selection, patient recruitment, rater training and overall clinical trial conduct. She consulted on issues related to health care systems in emerging markets, commercialization of product and establishment of strategic partnership.

Dr. Zhong has worked closely with patient advocacy groups, philanthropic organizations and research-orientated foundations, she has been actively engaged in public education and community activities on clinical research and education.

Dr. Zhong was featured in Los Angeles Business Journal (2009), Beverly Hills Life Style (2010), and Vegas Magazine (2011) for her scientific contributions to clinical research and drug development. Dr. Zhong has a US patent pending invention featuring technology enhancing quality of clinical trials.

Education & Fellowships

Residency - Baycrest Center for Geriatrics
Geriatric Psychiatry
Toronto, Ontario, CN
1995
Residency - Sunnybrook Hospital
Child Psychiatry
Ontario Canada
1994
Residency - Queen's Street Mental Health Center
Schizophrenia
Toronto, Ontario, CN
1993
Residency - Mount Sinai Hospital
Medical/Surgical Consultation
Toronto, Ontario Canada
1993
Residency - University of Toronto Hospitals
General Psychiatry/Psycho Pharmacology/Mood Disorder
Toronto, Ontario, Canada Canada
1992
Graduate - University of Toronto, Toronto, Ontario, Canada
Canada
1989
Medical School - West China University of Medical Sciences Faculty of Medicine
Chengdu China
1986

Certifications

  • Royal College of Physicians & Surgeons of Canada- Psychiatry

Specialty Interests

Alzheimer's, dementia, mild cognitive impairment, memory disorders, memory problems

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/19/2014, Dr. Zhong has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • Chinese
  • English